Literature DB >> 11459276

Opinions and commentary on treating pancreatic cancer.

R T Poon1, S T Fan.   

Abstract

Over the past 2 decades, major progress has been made in the perioperative and surgical management of pancreatic cancer. These advances have resulted in improved long-term results after surgical resection for pancreatic cancer. There are still many controversies surrounding the optimal management of this disease, however, resulting in wide variations in perioperative and operative care at different centers.

Entities:  

Mesh:

Year:  2001        PMID: 11459276     DOI: 10.1016/s0039-6109(05)70148-1

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

1.  Pancreatic resection for pancreatic cancer.

Authors:  Jeannine Bachmann; Christoph W Michalski; Marc E Martignoni; Markus W Büchler; Helmut Friess
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

2.  Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival.

Authors:  John D Allendorf; Margaret Lauerman; Aliye Bill; Mary DiGiorgi; Nicole Goetz; Efsevia Vakiani; Helen Remotti; Beth Schrope; William Sherman; Michael Hall; Robert L Fine; John A Chabot
Journal:  J Gastrointest Surg       Date:  2007-09-05       Impact factor: 3.452

3.  Pancreaticoduodenectomy with en bloc portal vein resection for pancreatic carcinoma with suspected portal vein involvement.

Authors:  Ronnie T Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Key Yuen; Chun Yeung; John Wong
Journal:  World J Surg       Date:  2004-06       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.